Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Roodhart, J"'
Autor:
Platt, J.R., Todd, O.M., Hall, P., Craig, Z., Quyn, A., Seymour, M., Braun, M., Roodhart, J., Punt, C., Christou, N., Taieb, J., Karoui, M., Brown, J., Cairns, D.A., Morton, D., Gilbert, A., Seligmann, J.F.
Publikováno v:
In ESMO Open February 2023 8(1)
Autor:
van den Berg, K., Wang, S., Willems, J. M. W. E., Creemers, G. J., Roodhart, J. M. L., Shkurti, J., Burger, J. W. A., Rutten, H. J. T., Beets-Tan, R. G. H., Nederend, J.
Publikováno v:
Abdominal Radiology; Feb2024, Vol. 49 Issue 2, p365-374, 10p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
van den Berg, K., Schaap, D. P., Voogt, E. L. K., Buffart, T. E., Verheul, H. M. W., de Groot, J. W. B., Verhoef, C., Melenhorst, J., Roodhart, J. M. L., de Wilt, J. H. W., van Westreenen, H. L., Aalbers, A. G. J., van 't Veer, M., Marijnen, C. A. M., Vincent, J., Simkens, L. H. J., Peters, N. A. J. B., Berbée, M., Werter, I. M., Snaebjornsson, P., Peulen, H. M. U., van Lijnschoten, I. G., Roef, M. J., Nieuwenhuijzen, G. A. P., Bloemen, J. G., Willems, J. M. W. E., Creemers, G. J. M., Nederend, J., Rutten, H. J. T., Burger, J. W. A.
Publikováno v:
BMC Cancer, 22(1):957. BioMed Central Ltd
BMC Cancer, 22(1):957. BioMed Central
BMC Cancer, 22
BMC Cancer, 22(1):957. BioMed Central Ltd.
BMC Cancer, 22, 1
van den Berg, K, Schaap, D P, Voogt, E L K, Buffart, T E, Verheul, H M W, de Groot, J W B, Verhoef, C, Melenhorst, J, Roodhart, J M L, de Wilt, J H W, van Westreenen, H L, Aalbers, A G J, van 't Veer, M, Marijnen, C A M, Vincent, J, Simkens, L H J, Peters, N A J B, Berbée, M, Werter, I M, Snaebjornsson, P, Peulen, H M U, van Lijnschoten, I G, Roef, M J, Nieuwenhuijzen, G A P, Bloemen, J G, Willems, J M W E, Creemers, G J M, Nederend, J, Rutten, H J T & Burger, J W A 2022, ' Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer : study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT) ', BMC Cancer, vol. 22, no. 1, 957, pp. 957 . https://doi.org/10.1186/s12885-022-09947-w
BMC Cancer, 22(1):957. BioMed Central
BMC Cancer, 22
BMC Cancer, 22(1):957. BioMed Central Ltd.
BMC Cancer, 22, 1
van den Berg, K, Schaap, D P, Voogt, E L K, Buffart, T E, Verheul, H M W, de Groot, J W B, Verhoef, C, Melenhorst, J, Roodhart, J M L, de Wilt, J H W, van Westreenen, H L, Aalbers, A G J, van 't Veer, M, Marijnen, C A M, Vincent, J, Simkens, L H J, Peters, N A J B, Berbée, M, Werter, I M, Snaebjornsson, P, Peulen, H M U, van Lijnschoten, I G, Roef, M J, Nieuwenhuijzen, G A P, Bloemen, J G, Willems, J M W E, Creemers, G J M, Nederend, J, Rutten, H J T & Burger, J W A 2022, ' Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer : study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT) ', BMC Cancer, vol. 22, no. 1, 957, pp. 957 . https://doi.org/10.1186/s12885-022-09947-w
Background The presence of mesorectal fascia (MRF) invasion, grade 4 extramural venous invasion (EMVI), tumour deposits (TD) or extensive or bilateral extramesorectal (lateral) lymph nodes (LLN) on MRI has been suggested to identify patients with ind
Autor:
Langenberg, M.H.G., Witteveen, P.O., Roodhart, J., Lolkema, M.P., Verheul, H.M.W., Mergui-Roelvink, M., Brendel, E., Krätzschmar, J., Loembé, B., Nol-Boekel, A., Christensen, O., Schellens, J.H.M., Voest, E.E. *
Publikováno v:
In Annals of Oncology November 2011 22(11):2508-2515
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
van den Berg, I., van de Weerd, S., van Klaveren, D., Coebergh van den Braak, R. R.J., van Krieken, J. H.J.M., Koopman, M., Roodhart, J. M.L., Medema, J. P., IJzermans, J. N.M.
Publikováno v:
European journal of surgical oncology, 47(8), 2060-2068. W.B. Saunders Ltd
European Journal of Surgical Oncology, 47(8), 2060-2068. W.B. Saunders
European Journal of Surgical Oncology, 47(8), 2060-2068. W.B. Saunders
Introduction: Although guidelines recommend adjuvant chemotherapy for stage III colon cancer patients, many patients do not receive adjuvant chemotherapy. The aim of this study was to identify reasons for guideline non-adherence and assess the effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::84d52fe3dcdff8f81877256ee9bc7af0
https://pure.amc.nl/en/publications/daily-practice-in-guideline-adherence-to-adjuvant-chemotherapy-in-stage-iii-colon-cancer-and-predictors-of-outcome(753ec553-5ac5-49c2-82ab-aae67d6e78ac).html
https://pure.amc.nl/en/publications/daily-practice-in-guideline-adherence-to-adjuvant-chemotherapy-in-stage-iii-colon-cancer-and-predictors-of-outcome(753ec553-5ac5-49c2-82ab-aae67d6e78ac).html
Autor:
van de Weerd, S., Hong, E., van den Berg, I., Wijlemans, J. W., van Vooren, J., Prins, M. W., Wessels, F. J., Heeres, B. C., Roberti, S., Nederend, J., van Krieken, J. H. J. M., Roodhart, J. M. L., Beets-Tan, R. G. H., Medema, J. P.
Publikováno v:
Abdominal Radiology; Oct2022, Vol. 47 Issue 10, p3375-3385, 11p
Autor:
Couwenberg, AM, Burbach, JPM, Berbee, M, Lacle, MM, Arensman, R, Raicu, MG, Wessels, FJ, Verdult, J, Roodhart, J, Reerink, O, Hoendervangers, S, Buijsen, J, Grabsch, H, Pronk, A, Consten, ECJ, Smits, AB, Heikens, JT, Appelt, AL, van Grevenstein, WMU, Verkooijen, HM, Intven, MPW
Purpose Pathological complete tumour response following chemoradiation in patients with locally advanced rectal cancer (LARC) is associated with favourable prognosis and allows organ-sparing treatment strategies. We aimed to investigate the effect of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::273fc20af2eccac05688f07df41928b7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.